This virtual conference will focus on key areas that may impact the success of drug development in 2027 and beyond, including:

• Bringing RWE earlier into clinical development to gain confidence in your decisions
• Understanding what evidence regulators are more likely to trust
• Exploring how digital twins and AI can help reshape trial design
• Learning how advanced monitoring technologies and AI‑driven analytics in Patient Experience Data can be used for early risk detection